The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

2025 — Our organs age at different rates, and a blood test determining how much they've each aged could predict the risk of conditions like lung cancer and heart disease decades later ...

Symptoms of both forms of MAC lung disease include the pervasive fatigue that you experienced. This is due to the extra work your body is doing to try to fight off the infection, and to the damage ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Understanding the scale of the problem is the first step to addressing it. Scientists issue stark warning about growing ...

It can be frustrating to diagnose HPS because there are no specific tests for it. To diagnose, doctors tend to look at the history of rodent exposure with accompanying fever and fatigue. So, its ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

But many different factors can affect your specific disease course. If your NSCLC is localized NSCLC, meaning it hasn’t spread outside your lung, your overall 5-year survival rate is 65%.

The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...